臨床試驗

SEEG-Guided DBS for OCD

NCT：NCT05623306 · RECRUITING

NCT IDNCT05623306

狀態RECRUITING

開始日期2023-04-13

完成時間2030-04-01

SponsorCasey H. Halpern, M.D. (OTHER)

First posted2022-11-21

Last updated2026-05-14

簡要摘要

This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open-label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of stimulation parameters. Stage 2 will consist of DBS surgery and further optimization of stimulation parameters. Stage 3 will be randomized, crossover treatment, followed by open-label treatment.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。